CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional  Paid-in Capital	Accumulated Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021		94,389,543
Beginning balance at Dec. 31, 2021	$ 2,886,311	$ 929	$ 2,351,294	$ 541,950	$ (7,862)
Increase (Decrease) in Stockholders' Equity
Net income	283,743			283,743
Other comprehensive (loss) income	(257,385)				(257,385)
Cash dividends declared	(125,160)			(125,160)
Dividend equivalents declared	0		493	(493)
Share-based compensation expense	18,925		18,925
Issuance of restricted stock, net (in shares)		827,761
Issuance of restricted stock, net	0	$ 4	(4)
Restricted stock surrendered and canceled (in shares)		(248,870)
Restricted stock surrendered and canceled	(8,918)		(8,918)
Exercise of stock options, net (in shares)		53,326
Exercise of stock options, net	873	$ 0	873
Ending balance (in shares) at Dec. 31, 2022		95,021,760
Ending balance at Dec. 31, 2022	2,798,389	$ 933	2,362,663	700,040	(265,247)
Increase (Decrease) in Stockholders' Equity
Net income	30,852			30,852
Other comprehensive (loss) income	165,622				165,622
Cash dividends declared	(126,265)			(126,265)
Dividend equivalents declared	0		490	(490)
Share-based compensation expense	19,390		19,390
Issuance of restricted stock, net (in shares)		1,085,234
Issuance of restricted stock, net	0	$ 4	(4)
Restricted stock surrendered and canceled (in shares)		(308,818)
Restricted stock surrendered and canceled	(6,373)		(6,373)
Exercise of stock options, net (in shares)		61,916
Exercise of stock options, net	$ 966	$ 1	965
Ending balance (in shares) at Dec. 31, 2023	95,860,092	95,860,092
Ending balance at Dec. 31, 2023	$ 2,882,581	$ 938	2,377,131	604,137	(99,625)
Increase (Decrease) in Stockholders' Equity
Net income	158,802			158,802
Other comprehensive (loss) income	23,819				23,819
Cash dividends declared	(127,108)			(127,108)
Dividend equivalents declared	0		563	(563)
Share-based compensation expense	21,717		21,717
Issuance of restricted stock, net (in shares)		822,001
Issuance of restricted stock, net	0	$ 3	(3)
Restricted stock surrendered and canceled (in shares)		(298,798)
Restricted stock surrendered and canceled	$ (4,976)		(4,976)
Exercise of stock options, net (in shares)	58,372	58,372
Exercise of stock options, net	$ 908	$ 1	907
Ending balance (in shares) at Dec. 31, 2024	96,441,667	96,441,667
Ending balance at Dec. 31, 2024	$ 2,955,743	$ 942	$ 2,395,339	$ 635,268	$ (75,806)